BillionToOne, Inc. filings document the regulatory record for a public molecular diagnostics company commercializing QCT-based prenatal and oncology testing. Recent Form 8-K disclosures furnish operating results, financial guidance, Regulation FD presentation materials and executive compensation arrangements, including the company’s annual incentive plan and equity-based payment provisions.
Proxy materials describe annual meeting mechanics, stockholder voting matters, board governance and related governance disclosures. Together, the filings address the company’s clinical testing revenue categories, Class A common stock compensation framework, furnished earnings materials and governance matters relevant to its Nasdaq-listed operating-company status.
Rai Akshay reported acquisition or exercise transactions in this Form 4 filing.
BillionToOne, Inc. director Akshay Rai received a grant of 3,017 restricted stock units (RSUs) linked to Class A Common Stock. Each RSU represents a right to receive one share for no cash payment. The RSUs vest when a service-based condition is met, on the earlier of the next annual stockholder meeting or the one-year anniversary of June 10, 2026. Following this equity award, Rai directly holds 14,026 shares of Class A Common Stock.
BillionToOne director Krishna Kittu Kolluri reported a series of restructuring transactions involving indirect holdings of Class A common stock. On 2026-06-09, entities associated with Kolluri completed 16 “J” code transactions classified as other acquisitions or dispositions, covering 481,807 shares in total.
The footnotes explain these were pro-rata, in-kind distributions among multiple Neotribe investment funds, special purpose vehicles, and family trusts, all for no additional consideration and not open-market trades. The securities are held directly by these entities, where Kolluri serves as managing member or trustee, and he disclaims beneficial ownership except to the extent of his pecuniary interest.
Investment entities affiliated with NeoTribe, including NeoTribe Ventures and multiple related funds and LLCs, reported a series of internal restructuring transactions in BillionToOne, Inc. Class A Common Stock. All ten transactions were coded as “J” for other acquisitions or dispositions and totaled 465,607 shares, with a reported price of $0.00 per share, indicating no cash consideration.
Footnotes explain these were pro-rata, in-kind distributions by funds and special purpose vehicles such as Neotribe Ignite Fund I, L.P., Neotribe SPV I BTO, LLC, NeoTribe Ventures I, L.P., NeoTribe Associates I, L.P., and NeoTribe Partners I, LLC to their partners or members. Following these changes, one entity directly holds 2,168,230 shares and another indirectly holds 1,038,239 shares, while smaller indirect holdings of 193,772, 7,980, 5,423 and 1,425 shares are reported, reflecting a reallocation among affiliated investment vehicles rather than open-market trades.
BillionToOne, Inc. Chief Product Officer Sakakibara Shan Riku reported open-market sales of 8,000 shares of Class A Common Stock on June 8, 2026. The transactions were executed in two tranches at prices of $100.00 and $96.45 per share under a pre-arranged Rule 10b5-1 trading plan.
The filing indicates these were routine, pre-planned dispositions, and the executive continues to hold a substantially larger direct equity position after the sales.
BillionToOne, Inc. officer Nancy JoAnn Johnson reported open-market sales of 14,000 shares of Class A Common Stock on June 8–9, 2026. The shares were sold in seven transactions at weighted-average prices generally around $99–$102 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.
BillionToOne, Inc. director and officer Atay Oguzhan reported multiple transactions in the company’s Class A and Class B common stock. On June 8, 2026, he acquired a total of 36,250 shares of Class A common stock through option exercises and conversion of Class B shares at prices from $0.00 to $2.80 per share.
That same day, 38,750 shares of Class A common stock were sold in open-market transactions at weighted-average prices ranging from about $94.30 to $100.87, including sales of shares held by his spouse. On June 9, 2026, he made a bona fide gift of 10,000 Class A shares. The transactions were effected under a Rule 10b5-1 trading plan adopted on March 6, 2026.
BLLN affiliate files Form 144 to report proposed resale of Class A shares. The notice lists multiple blocks of Pre-IPO Class A shares dated 01/07/2020, 05/05/2020, and 07/03/2020 totaling discrete lots of 6,582, 3,200, and 800 shares respectively. The filing also discloses a sale in the past three months by Nancy J. Johnson of 3,418 Class A shares for $339,347.28 on 06/08/2026.